These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 11791081)
1. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. Sitruk-Ware R Menopause; 2002; 9(1):6-15. PubMed ID: 11791081 [TBL] [Abstract][Full Text] [Related]
2. Progestins in the menopause. Sitruk-Ware R J Steroid Biochem Mol Biol; 1999; 69(1-6):185-93. PubMed ID: 10418992 [TBL] [Abstract][Full Text] [Related]
3. The rationale for a wider range of progestogens. Skouby SO Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382 [TBL] [Abstract][Full Text] [Related]
4. New progestogens: a review of their effects in perimenopausal and postmenopausal women. Sitruk-Ware R Drugs Aging; 2004; 21(13):865-83. PubMed ID: 15493951 [TBL] [Abstract][Full Text] [Related]
5. Pharmacology of different progestogens: the special case of drospirenone. Sitruk-Ware R Climacteric; 2005 Oct; 8 Suppl 3():4-12. PubMed ID: 16203650 [TBL] [Abstract][Full Text] [Related]
6. A review of the cardiovascular and breast actions of drospirenone in preclinical studies. Simoncini T; Genazzani AR Climacteric; 2010 Feb; 13(1):22-33. PubMed ID: 19938948 [TBL] [Abstract][Full Text] [Related]
8. New progestagens for contraceptive use. Sitruk-Ware R Hum Reprod Update; 2006; 12(2):169-78. PubMed ID: 16291771 [TBL] [Abstract][Full Text] [Related]
9. Micronized progesterone and its impact on the endometrium and breast vs. progestogens. Gompel A Climacteric; 2012 Apr; 15 Suppl 1():18-25. PubMed ID: 22432812 [TBL] [Abstract][Full Text] [Related]
10. Hormone therapy and the cardiovascular system: the critical role of progestins. Sitruk-Ware RL Climacteric; 2003 Oct; 6 Suppl 3():21-8. PubMed ID: 15018245 [TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacology of newer progestogens. Kuhl H Drugs; 1996 Feb; 51(2):188-215. PubMed ID: 8808163 [TBL] [Abstract][Full Text] [Related]
12. Progestins and cardiovascular risk markers. Sitruk-Ware R Steroids; 2000; 65(10-11):651-8. PubMed ID: 11108872 [TBL] [Abstract][Full Text] [Related]
14. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729 [TBL] [Abstract][Full Text] [Related]
15. The role of antiandrogens in hormone replacement therapy. Schneider HP Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of progestins. Sitruk-Ware R Maturitas; 2004 Apr; 47(4):277-83. PubMed ID: 15063480 [TBL] [Abstract][Full Text] [Related]
17. Risks of estrogens and progestogens. L'Hermite M Maturitas; 1990 Sep; 12(3):215-46. PubMed ID: 2170823 [TBL] [Abstract][Full Text] [Related]
18. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
19. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women. Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909 [TBL] [Abstract][Full Text] [Related]
20. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Gambrell RD Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]